Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Quarterly results
Director departure
CC transcript
|
|
ALBIREO PHARMA, INC. (ALBO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/03/2023 |
4
| Chiswell David (Director) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Unknown transaction of 56,278 shares
@ $0
Disposed/sold 8,000 options to buy
@ $19.47, valued at
$155.8k
Disposed/sold 8,000 options to buy
@ $36.87, valued at
$295k
Disposed/sold 8,000 options to buy
@ $27.89, valued at
$223.1k
Disposed/sold 5,500 options to buy
@ $31.22, valued at
$171.7k
Disposed/sold 5,500 options to buy
@ $32.53, valued at
$178.9k
Disposed/sold 3,000 options to buy
@ $17.05, valued at
$51.2k
Disposed/sold 4,500 options to buy
@ $18.54, valued at
$83.4k
|
|
| 03/02/2023 |
4
| Alesina Susan (Director) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Disposed/sold 16,000 options to buy
@ $25.86, valued at
$413.8k
|
|
| 03/02/2023 |
4
| Okey Stephanie (Director) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Disposed/sold 8,000 options to buy
@ $19.47, valued at
$155.8k
Disposed/sold 8,000 options to buy
@ $36.87, valued at
$295k
Disposed/sold 8,000 options to buy
@ $27.89, valued at
$223.1k
Disposed/sold 5,500 options to buy
@ $31.22, valued at
$171.7k
Disposed/sold 5,500 options to buy
@ $32.53, valued at
$178.9k
Disposed/sold 11,000 options to buy
@ $30.68, valued at
$337.5k
|
|
| 03/02/2023 |
4
| Harford Simon N.R. (CFO and Treasurer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Unknown transaction of 13,739 shares
@ $0
Disposed/sold 23,700 options to buy
@ $34.88, valued at
$826.7k
Disposed/sold 31,500 options to buy
@ $24.67, valued at
$777.1k
Disposed/sold 31,500 options to buy
@ $24.04, valued at
$757.3k
Disposed/sold 37,500 options to buy
@ $27.98, valued at
$1M
Disposed/sold 73,950 restricted stock units
@ $0 |
|
| 03/02/2023 |
4
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Unknown transaction of 33,094 shares
@ $0
Disposed/sold 132,150 options to buy
@ $26.75, valued at
$3.5M
Disposed/sold 43,027 options to buy
@ $19.19, valued at
$825.7k
Disposed/sold 93,000 options to buy
@ $34.88, valued at
$3.2M
Disposed/sold 124,000 options to buy
@ $24.67, valued at
$3.1M
Disposed/sold 124,000 options to buy
@ $24.04, valued at
$3M
Disposed/sold 123,750 options to buy
@ $30.68, valued at
$3.8M
Disposed/sold 60,000 options to buy
@ $24.48, valued at
$1.5M
Disposed/sold 19,422 options to buy
@ $1, valued at
$19.4k
Disposed/sold 155,381 options to buy
@ $1, valued at
$155.4k
Disposed/sold 219,350 restricted stock units
@ $0 |
|
| 03/02/2023 |
4
| STRECK PAUL (Chief Medical Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Disposed/sold 118,966 restricted stock units
@ $0 |
|
| 03/02/2023 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Unknown transaction of 22,242 shares
@ $0
Disposed/sold 23,700 options to buy
@ $34.88, valued at
$826.7k
Disposed/sold 31,500 options to buy
@ $24.67, valued at
$777.1k
Disposed/sold 37,500 options to buy
@ $28.76, valued at
$1.1M
Disposed/sold 75,513 restricted stock units
@ $0 |
|
| 03/02/2023 |
4
| Graham Michelle (Chief Human Resources Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Unknown transaction of 5,543 shares
@ $0
Disposed/sold 23,700 options to buy
@ $34.88, valued at
$826.7k
Disposed/sold 31,500 options to buy
@ $24.67, valued at
$777.1k
Disposed/sold 37,500 options to buy
@ $19.32, valued at
$724.5k
Disposed/sold 50,950 restricted stock units
@ $0 |
|
| 03/02/2023 |
4
| Gutch Michael (Director) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Disposed/sold 8,000 options to buy
@ $19.47, valued at
$155.8k
Disposed/sold 8,000 options to buy
@ $36.87, valued at
$295k
Disposed/sold 8,000 options to buy
@ $27.89, valued at
$223.1k
Disposed/sold 5,500 options to buy
@ $31.22, valued at
$171.7k
Disposed/sold 5,500 options to buy
@ $32.53, valued at
$178.9k
Disposed/sold 3,000 options to buy
@ $17.05, valued at
$51.2k
Disposed/sold 4,500 options to buy
@ $23.82, valued at
$107.2k
|
|
| 03/02/2023 |
4
| Carter Martha J. (Chief Regulatory Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Unknown transaction of 3,656 shares
@ $0
Disposed/sold 15,900 options to buy
@ $26.75, valued at
$425.3k
Disposed/sold 23,700 options to buy
@ $34.88, valued at
$826.7k
Disposed/sold 3,250 options to buy
@ $24.48, valued at
$79.6k
Disposed/sold 62,009 options to buy
@ $29.76, valued at
$1.8M
Disposed/sold 2,500 options to buy
@ $19.19, valued at
$48k
Disposed/sold 19,688 options to buy
@ $24.04, valued at
$473.3k
Disposed/sold 31,500 options to buy
@ $24.67, valued at
$777.1k
Disposed/sold 30,000 options to buy
@ $30.68, valued at
$920.4k
Disposed/sold 65,850 restricted stock units
@ $0 |
|
| 03/02/2023 |
4
| Duncan Jason (Chief Legal Officer and GC) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Unknown transaction of 3,296 shares
@ $0
Disposed/sold 15,900 options to buy
@ $26.75, valued at
$425.3k
Disposed/sold 10,063 options to buy
@ $24.04, valued at
$241.9k
Disposed/sold 24,337 options to buy
@ $24.67, valued at
$600.4k
Disposed/sold 23,700 options to buy
@ $34.88, valued at
$826.7k
Disposed/sold 37,500 options to buy
@ $30.68, valued at
$1.2M
Disposed/sold 65,850 restricted stock units
@ $0 |
|
| 03/02/2023 |
4
| Mattsson Jan (Chief Scientific Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Unknown transaction of 35,524 shares
@ $0
Disposed/sold 23,700 options to buy
@ $34.88, valued at
$826.7k
Disposed/sold 31,500 options to buy
@ $24.67, valued at
$777.1k
Disposed/sold 31,500 options to buy
@ $24.04, valued at
$757.3k
Disposed/sold 40,000 options to buy
@ $30.68, valued at
$1.2M
Disposed/sold 13,000 options to buy
@ $24.48, valued at
$318.2k
Disposed/sold 20,000 options to buy
@ $19.19, valued at
$383.8k
Disposed/sold 73,950 restricted stock units
@ $0 |
|
| 03/02/2023 |
4
| Dable Habib J (Director) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Disposed/sold 16,000 options to buy
@ $25.86, valued at
$413.8k
|
|
| 03/02/2023 |
4
| SCOON DAVEY (Director) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Disposed/sold 8,000 options to buy
@ $19.47, valued at
$155.8k
Disposed/sold 8,000 options to buy
@ $36.87, valued at
$295k
Disposed/sold 8,000 options to buy
@ $27.89, valued at
$223.1k
Disposed/sold 5,500 options to buy
@ $31.22, valued at
$171.7k
Disposed/sold 5,500 options to buy
@ $32.53, valued at
$178.9k
Disposed/sold 3,000 options to buy
@ $17.05, valued at
$51.2k
Disposed/sold 4,500 options to buy
@ $18.54, valued at
$83.4k
Disposed/sold 333 options to buy
@ $39.6, valued at
$13.2k
Disposed/sold 3,333 options to buy
@ $9, valued at
$30k
|
|
| 03/02/2023 |
4
| Hopkinson Craig C. (Director) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Disposed/sold 10,495 restricted stock units
@ $0 |
|
| 01/25/2023 |
4
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 195,000 shares
@ $0 |
|
| 01/25/2023 |
4
| Mattsson Jan (Chief Scientific Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 55,000 shares
@ $0 |
|
| 01/25/2023 |
4
| Carter Martha J. (Chief Regulatory Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 55,000 shares
@ $0 |
|
| 01/25/2023 |
4
| Duncan Jason (Chief Legal Officer and GC) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 55,000 shares
@ $0 |
|
| 01/25/2023 |
4
| Graham Michelle (Chief Human Resources Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 32,000 shares
@ $0 |
|
| 01/25/2023 |
4
| Harford Simon N.R. (CFO and Treasurer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 55,000 shares
@ $0 |
|
| 01/25/2023 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 55,000 shares
@ $0 |
|
| 01/25/2023 |
4
| STRECK PAUL (Chief Medical Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 55,000 shares
@ $0 |
|
| 01/23/2023 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 102 shares
@ $43.8, valued at
$4.5k
|
|
| 01/23/2023 |
4
| Graham Michelle (Chief Human Resources Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 102 shares
@ $43.8, valued at
$4.5k
|
|
| 01/23/2023 |
4
| Mattsson Jan (Chief Scientific Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 197 shares
@ $43.8, valued at
$8.6k
|
|
| 01/23/2023 |
4
| Harford Simon N.R. (CFO and Treasurer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 102 shares
@ $43.8, valued at
$4.5k
|
|
| 01/23/2023 |
4
| Duncan Jason (Chief Legal Officer and GC) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 228 shares
@ $43.8, valued at
$10k
|
|
| 01/23/2023 |
4
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 1,057 shares
@ $43.8, valued at
$46.3k
|
|
| 01/23/2023 |
4
| Carter Martha J. (Chief Regulatory Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 120 shares
@ $43.8, valued at
$5.3k
|
|
| 01/20/2023 |
4
| Carter Martha J. (Chief Regulatory Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 938 shares
@ $43.9044, valued at
$41.2k
|
|
| 01/20/2023 |
4
| Duncan Jason (Chief Legal Officer and GC) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 938 shares
@ $43.9044, valued at
$41.2k
|
|
| 01/20/2023 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 1,774 shares
@ $43.9044, valued at
$77.9k
|
|
| 01/20/2023 |
4
| Mattsson Jan (Chief Scientific Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 3,088 shares
@ $43.8, valued at
$135.3k
|
|
|
|
|